Change in IOP Fluctuation After DSLT
NCT: NCT07428668 · RECRUITING
Brief Summary
This is a prospective, single-center, single-arm, observational study designed to evaluate the change in diurnal intraocular pressure (IOP) fluctuation following Direct Selective Laser Trabeculoplasty (DSLT) in patients with primary open-angle glaucoma (POAG) who are on 1-3 IOP lowering medications. The study will be conducted at one site and will involve three key visits: a screening visit, a baseline/treatment visit, and a 6-month follow-up visit. During the screening visit, patients will undergo a comprehensive ophthalmic examination, and eligibility will be confirmed. The eye with the higher IOP will be selected if both eyes are eligible. At the baseline visit, diurnal IOP will be recorded at three time points (9am, 12pm, and 4pm) before DSLT is performed. The primary endpoint is the change in diurnal IOP fluctuation 6 months post-treatment. Secondary endpoints include changes in mean diurnal IOP and the proportion of eyes achieving a reduction in IOP fluctuations of ≥1 mmHg. Exploratory endpoints focus on demographic variables associated with IOP fluctuation changes.
Frequently Asked Questions
What is Change in IOP Fluctuation After DSLT?
Change in IOP Fluctuation After DSLT is a clinical trial registered under NCT07428668. Current status: RECRUITING.
What is the status of NCT07428668?
The current status of NCT07428668 (Change in IOP Fluctuation After DSLT) is: RECRUITING.
When did Change in IOP Fluctuation After DSLT start?
Change in IOP Fluctuation After DSLT started on 2026-04-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.